PROVECTUS BIOPHARMACEUTICALS, INC.
Ownership & governance
Executives 3Directors 4Avg age 64Avg tenure 7.7y
EP
Edward Pershing
Chief Executive Officer
Age 73Since 2024-04-15Profile →
+6
Executives3
EP
Edward Pershing→
Chief Executive Officer
Age 73Since 2024-04-15
EW
Eric Wachter
Chief Tech/Sci/R&D Officer
Age 62Since 2012-05-14
HR
Heather Raines
Director of Finance/CFO
Age 59Since 2019-03-24
Board of directors4
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Jeffrey A Morris | 4.402 % | 18,500,000 |
| Eric Wachter | 1.582 % | 6,649,298 |
| Edward Pershing | 0.752 % | 3,160,380 |
| Bruce Horowitz | 0.637 % | 2,677,243 |
| Dominic Rodrigues | 0.2564 % | 1,077,389 |
Catalog · 2026-07-09
Registry officers6
| Name | Role | Since | Shares |
|---|---|---|---|
| Dominic Rodrigues | Chairman | 2017-04-02 | - |
| Edward Pershing | Chairman | 2018-04-26 | - |
| John Lacey | Director/Board Member | 2018-04-26 | - |
| John Lacey, III, M.D | Director or executive officer | 2018-01-01 | 975,082 |
| Webster Bailey | Director/Board Member | 2020-07-19 | - |
| Webster Bailey | Director or executive officer | 2020-01-01 | 1,333,850 |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.